225 related articles for article (PubMed ID: 27406709)
21. Adaptor-Specific Antibody Fragment Inhibitors for the Intracellular Modulation of p97 (VCP) Protein-Protein Interactions.
Jiang Z; Kuo YH; Zhong M; Zhang J; Zhou XX; Xing L; Wells JA; Wang Y; Arkin MR
J Am Chem Soc; 2022 Jul; 144(29):13218-13225. PubMed ID: 35819848
[TBL] [Abstract][Full Text] [Related]
22. AAA ATPase p97/VCP is essential for TRIM21-mediated virus neutralization.
Hauler F; Mallery DL; McEwan WA; Bidgood SR; James LC
Proc Natl Acad Sci U S A; 2012 Nov; 109(48):19733-8. PubMed ID: 23091005
[TBL] [Abstract][Full Text] [Related]
23. Valosin-containing protein (p97) is a regulator of endoplasmic reticulum stress and of the degradation of N-end rule and ubiquitin-fusion degradation pathway substrates in mammalian cells.
Wójcik C; Rowicka M; Kudlicki A; Nowis D; McConnell E; Kujawa M; DeMartino GN
Mol Biol Cell; 2006 Nov; 17(11):4606-18. PubMed ID: 16914519
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of p97/VCP function leads to defective autophagosome maturation, cell cycle arrest and apoptosis in mouse Sertoli cells.
Cayli S; Sahin C; Sanci TO; Nakkas H
Theriogenology; 2020 Dec; 158():196-206. PubMed ID: 32966945
[TBL] [Abstract][Full Text] [Related]
25. Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.
Heidelberger JB; Voigt A; Borisova ME; Petrosino G; Ruf S; Wagner SA; Beli P
EMBO Rep; 2018 Apr; 19(4):. PubMed ID: 29467282
[TBL] [Abstract][Full Text] [Related]
26. VCP/p97 AAA-ATPase does not interact with the endogenous wild-type cystic fibrosis transmembrane conductance regulator.
Goldstein RF; Niraj A; Sanderson TP; Wilson LS; Rab A; Kim H; Bebok Z; Collawn JF
Am J Respir Cell Mol Biol; 2007 Jun; 36(6):706-14. PubMed ID: 17272822
[TBL] [Abstract][Full Text] [Related]
27. Structural basis of the interaction between the AAA ATPase p97/VCP and its adaptor protein p47.
Dreveny I; Kondo H; Uchiyama K; Shaw A; Zhang X; Freemont PS
EMBO J; 2004 Mar; 23(5):1030-9. PubMed ID: 14988733
[TBL] [Abstract][Full Text] [Related]
28. A VCP inhibitor substrate trapping approach (VISTA) enables proteomic profiling of endogenous ERAD substrates.
Huang EY; To M; Tran E; Dionisio LTA; Cho HJ; Baney KLM; Pataki CI; Olzmann JA
Mol Biol Cell; 2018 May; 29(9):1021-1030. PubMed ID: 29514927
[TBL] [Abstract][Full Text] [Related]
29. ATPase activity of p97-valosin-containing protein (VCP). D2 mediates the major enzyme activity, and D1 contributes to the heat-induced activity.
Song C; Wang Q; Li CC
J Biol Chem; 2003 Feb; 278(6):3648-55. PubMed ID: 12446676
[TBL] [Abstract][Full Text] [Related]
30. The Ankrd13 Family of Ubiquitin-interacting Motif-bearing Proteins Regulates Valosin-containing Protein/p97 Protein-mediated Lysosomal Trafficking of Caveolin 1.
Burana D; Yoshihara H; Tanno H; Yamamoto A; Saeki Y; Tanaka K; Komada M
J Biol Chem; 2016 Mar; 291(12):6218-31. PubMed ID: 26797118
[TBL] [Abstract][Full Text] [Related]
31. Using the Ubiquitin-modified Proteome to Monitor Distinct and Spatially Restricted Protein Homeostasis Dysfunction.
Gendron JM; Webb K; Yang B; Rising L; Zuzow N; Bennett EJ
Mol Cell Proteomics; 2016 Aug; 15(8):2576-93. PubMed ID: 27185884
[TBL] [Abstract][Full Text] [Related]
32. Endotoxin conditioning induces VCP/p97-mediated and inducible nitric-oxide synthase-dependent Tyr284 nitration in protein phosphatase 2A.
Ohama T; Brautigan DL
J Biol Chem; 2010 Mar; 285(12):8711-8. PubMed ID: 20100830
[TBL] [Abstract][Full Text] [Related]
33. The heavy metal cadmium induces valosin-containing protein (VCP)-mediated aggresome formation.
Song C; Xiao Z; Nagashima K; Li CC; Lockett SJ; Dai RM; Cho EH; Conrads TP; Veenstra TD; Colburn NH; Wang Q; Wang JM
Toxicol Appl Pharmacol; 2008 May; 228(3):351-63. PubMed ID: 18261755
[TBL] [Abstract][Full Text] [Related]
34. Physical and functional interaction between Dorfin and Valosin-containing protein that are colocalized in ubiquitylated inclusions in neurodegenerative disorders.
Ishigaki S; Hishikawa N; Niwa J; Iemura S; Natsume T; Hori S; Kakizuka A; Tanaka K; Sobue G
J Biol Chem; 2004 Dec; 279(49):51376-85. PubMed ID: 15456787
[TBL] [Abstract][Full Text] [Related]
35. D1 ring is stable and nucleotide-independent, whereas D2 ring undergoes major conformational changes during the ATPase cycle of p97-VCP.
Wang Q; Song C; Yang X; Li CC
J Biol Chem; 2003 Aug; 278(35):32784-93. PubMed ID: 12807884
[TBL] [Abstract][Full Text] [Related]
36. The p97/VCP adaptor UBXD1 drives AAA+ remodeling and ring opening through multi-domain tethered interactions.
Braxton JR; Altobelli CR; Tucker MR; Tse E; Thwin AC; Arkin MR; Southworth DR
Nat Struct Mol Biol; 2023 Dec; 30(12):2009-2019. PubMed ID: 37945741
[TBL] [Abstract][Full Text] [Related]
37. Identification of VCP/p97, carboxyl terminus of Hsp70-interacting protein (CHIP), and amphiphysin II interaction partners using membrane-based human proteome arrays.
Grelle G; Kostka S; Otto A; Kersten B; Genser KF; Müller EC; Wälter S; Böddrich A; Stelzl U; Hänig C; Volkmer-Engert R; Landgraf C; Alberti S; Höhfeld J; Strödicke M; Wanker EE
Mol Cell Proteomics; 2006 Feb; 5(2):234-44. PubMed ID: 16275660
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of autophagy, lysosome and VCP function impairs stress granule assembly.
Seguin SJ; Morelli FF; Vinet J; Amore D; De Biasi S; Poletti A; Rubinsztein DC; Carra S
Cell Death Differ; 2014 Dec; 21(12):1838-51. PubMed ID: 25034784
[TBL] [Abstract][Full Text] [Related]
39. Identification of SVIP as an endogenous inhibitor of endoplasmic reticulum-associated degradation.
Ballar P; Zhong Y; Nagahama M; Tagaya M; Shen Y; Fang S
J Biol Chem; 2007 Nov; 282(47):33908-14. PubMed ID: 17872946
[TBL] [Abstract][Full Text] [Related]
40. Characterization of the aggregation-prevention activity of p97/valosin-containing protein.
Song C; Wang Q; Li CC
Biochemistry; 2007 Dec; 46(51):14889-98. PubMed ID: 18044963
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
